Abstract
Many advances have been made in understanding the role of transcription factors in different types of cancer. With colorectal cancer being the third most commonly diagnosed cancer, studying critical transcription factors such as the lymphoid enhancer factor/T-cell factor (LEF/TCF) transcription factor family may assist in understanding its growth and progression but also serve as a therapeutic target in hopes for better patient outcomes. This chapter will discuss the pathway LEF/TCF transcription factors are known to be involved in, their regulation, and current studies that have investigated their role and function in colorectal cancer and normal cell maintenance.
The original version of this chapter was revised. The book was inadvertently published without Abstracts and Keywords, which are now included in all the chapters. An erratum to this chapter can be found at https://doi.org/10.1007/978-981-10-6728-0_39
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Barker N (2008) The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 468:5–15
Miller JR (2002) The Wnts. Genome Biol 3(1):1–9
Hobmayer B et al (2000) WNT signalling molecules act in axis formation in the diploblastic metazoan hydra. Nature 407(6801):186–189
Grimson MJ et al (2000) Adherens junctions and beta-catenin-mediated cell signalling in a non-metazoan organism. Nature 408(6813):727–731
Miyoshi Y et al (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci 89(10):4452–4456
Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149(6):1192–1205
van de Wetering M et al (1993) Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 12(10):3847–3854
Brunner E et al (1997) Pangolin encodes a Lef-1 homologue that acts downstream of armadillo to transduce the wingless signal in drosophila. Nature 385(6619):829–833
van de Wetering M et al (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111(2):241–250
Lin R, Hill RJ, Priess JR (1998) POP-1 and anterior-posterior fate decisions in C. elegans embryos. Cell 92(2):229–239
van Amerongen R, Berns A (2006) Knockout mouse models to study Wnt signal transduction. Trends Genet 22(12):678–689
Colorectal Cancer Facts & Figures 2014–2016. 2014, American Cancer Society.
Oosterwegel M et al (1991) Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers. J Exp Med 173(5):1133–1142
van de Wetering M et al (1991) Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J 10(1):123–132
Travis A et al (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 5(5):880–894
Arce L, Pate KT, Waterman ML (2009) Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer 9:159
Maduro MF et al (2005) The Wnt effector POP-1 and the PAL-1/caudal homeoprotein collaborate with SKN-1 to activate C. elegans endoderm development. Dev Biol 285(2):510–523
Shetty P et al (2005) C. elegans TCF protein, POP-1, converts from repressor to activator as a result of Wnt-induced lowering of nuclear levels. Dev Biol 285(2):584–592
El-Tanani M et al (2004) Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279(20):20794–20806
Behrens J et al (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382(6592):638–642
Rao TP, Kuhl M (2010) An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 106(12):1798–1806
Shtutman M et al (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96(10):5522–5527
Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398(6726):422–426
He TC et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281(5382):1509–1512
Gradl D, Kuhl M, Wedlich D (1999) The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol 19(8):5576–5587
ten Berge D et al (2008) Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development 135(19):3247–3257
He TC et al (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99(3):335–345
Mann B et al (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96(4):1603–1608
Conacci-Sorrell ME et al (2002) Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 16(16):2058–2072
Hovanes K et al (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28(1):53–57
Li TW et al (2006) Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Biol 26(14):5284–5299
Hovanes K, Li TW, Waterman ML (2000) The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28(9):1994–2003
Jimenez J et al (2005) An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA 11(9):1385–1399
Kikuchi A, Kishida S, Yamamoto H (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38(1):1–10
Ishitani T et al (1999) The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399(6738):798–802
Ishitani T et al (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca[2+] pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23(1):131–139
Brannon M et al (1997) A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 11(18):2359–2370
Daniels DL, Weis WI (2005) Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12(4):364–371
Arce L, Yokoyama NN, Waterman ML (2006) Diversity of LEF/TCF action in development and disease. Oncogene 25(57):7492–7504
Hoppler S, Kavanagh CL (2007) Wnt signalling: variety at the core. J Cell Sci 120(Pt 3):385–393
Ding Y et al. (2014) The S-G2 phase enriched β-catenin/TCF complex ensures cell survival and cell cycle progression. J Cell Sci 127:4834–4840
Morgan DO (1995) Principles of CDK regulation. Nature 374(6518):131–134
Matsushime H, Roussel MF, Sherr CJ (1991) Novel mammalian cyclins [CYL genes] expressed during G1. Cold Spring Harb Symp Quant Biol 56:69–74
Baldin V et al (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7(5):812–821
Mermelshtein A et al (2005) Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer 93(3):338–345
Arber N et al (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110(3):669–674
Sutter T et al (1997) Expression of cyclins D1 and E in human colon adenocarcinomas. J Med 28(5–6):285–309
Bukholm IK, Nesland JM (2000) Protein expression of p53, p21 [WAF1/CIP1], bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436(3):224–228
Arber N et al (1997) Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 57(8):1569–1574
Korinek V et al (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19(4):379–383
Lecuit T, Lenne PF (2007) Cell surface mechanics and the control of cell shape, tissue patterns and morphogenesis. Nat Rev Mol Cell Biol 8(8):633–644
Vlad-Fiegen A et al (2012) The Wnt pathway destabilizes adherens junctions and promotes cell migration via beta-catenin and its target gene cyclin D1. FEBS Open Biol 2:26–31
Sánchez-Tilló E et al (2011) β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition [EMT]-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci 108(48):19204–19209
Planutis K, Planutiene M, Holcombe RF (2010) Abstract LB-367: Wnt-dependent transcription factor LEF-1 controls endothelial cell invasion through changes of MMP-2 expression. Cancer Res 70(8 Supplement):LB-367-LB-367
Medici D, Hay ED, Olsen BR (2008) Snail and slug promote epithelial-mesenchymal transition through β-Catenin–T-Cell Factor-4-dependent expression of transforming growth factor-β3. Mol Biol Cell 19(11):4875–4887
Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50(19):6130–6138
Rothbarth J, van de Velde CJ (2005) Treatment of liver metastases of colorectal cancer. Ann Oncol 16(Suppl 2):ii144–ii149
Gallagher DJ, Kemeny N (2010) Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78(3–4):237–248
Li Y et al (2011) HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene 30(23):2633–2643
Dai Y et al (2017) Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells. Oncotarget 8(6):9783–9793
Ratner M (2004) Genentech discloses safety concerns over Avastin. Nat Biotechnol 22(10):1198
Ellis LM (2004) Epidermal growth factor receptor in tumor angiogenesis. Hematol Oncol Clin North Am 18(5):1007–1021. viii
Takahashi Y et al (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55(18):3964–3968
Mar AC et al (2015) Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis. J Biol Chem 290(36):22212–22224
Clifford RL, Deacon K, Knox AJ (2008) Novel regulation of vascular endothelial growth factor-A [VEGF-A] by transforming growth factor [beta]1: requirement for Smads, [beta]-CATENIN, AND GSK3[beta]. J Biol Chem 283(51):35337–35353
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Wang SH et al (2012) The balance between two isoforms of LEF-1 regulates colon carcinoma growth. BMC Gastroenterol 12:53
Reya T et al (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423(6938):409–414
Ng TB, Liu F, Wang ZT (2000) Antioxidative activity of natural products from plants. Life Sci 66(8):709–723
Cai Y et al (2004) Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 74(17):2157–2184
Kaneko T, Tahara S, Takabayashi F (2007) Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons. Biol Pharm Bull 30(11):2052–2057
Lepourcelet M et al (2004) Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5(1):91–102
Sommer T, Hirsch C (2005) San1p, checking up on nuclear proteins. Cell 120(6):736–734
Liu J et al (2006) The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. J Mol Biol 360(1):133–144
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd
About this chapter
Cite this chapter
Bastien, A.J. (2017). LEF/TCF: Its Role in Colon Cancer. In: Nagaraju, G., Bramhachari, P. (eds) Role of Transcription Factors in Gastrointestinal Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-10-6728-0_22
Download citation
DOI: https://doi.org/10.1007/978-981-10-6728-0_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6727-3
Online ISBN: 978-981-10-6728-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)